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The aim of this study was to determine the prevalence of 
Hepatitis C Virus (HCV) and Human Cytomegalovirus (HCMV) 
among hemodialysis machines, A study was conducted during 
the period from April to December 2019.   Blood samples were 
collected in sterile containers from different hospitals from 
both males and females with different ages and kept in deep 
freezer at (-34C) until lab test. Sera of 91 hemodialysis patients 
were investigated for HCV and CMV   , enzyme-linked immune 
sorbent assay ELISA – IgM we found that for HCV: ninety one 
samples were negative for anti IgM-HCV, and we found that for 
HCMV   eight samples ( 7.3%) were positive for anti IgM:  Giad 
hospital three   (2.7%) were positive, two males (1.82%),  ( ages 
49 ,29 years), one female was positive  (0.9%), aged 37years    
,Police hospital three  (2.7%)  positive, one female was 
positive,( 0.9%)  aged 48 years , and two males (ages were 
54,67 years) were positive (1.8%)  ,Bashar one male was 
positive ( age 89 years ),  Academy one male was positive 

















enzyme-linked immune sorbent 
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1.1 Introduction                                                                       
Chronic renal failure (CRF) is defined as an irreversible 
reduction in glomerular filtration rate (GFR), the prevalence of 
CRF in the pediatric population is approximately 18 per 1 
million
. 
(Vogt etal., 1999). In CRF almost every system in the 
body eventually becomes compromised (Chan et al., 2002). Hyper 
filtration injury is proposed to be an important final common 
pathway of glomerular destruction. As enthrones are lost, the 
remaining nephrons undergo structural and functional 
hypertrophy with increased glomerular blood flow. Although 
this compensatory hyper filtration temporarily preserves total 
renal function, it is theorized to cause progressive damage to the 
surviving glomeruli possibly by a direct effect of the elevated 
hydrostatic pressure on the integrity of the capillary wall and /or 
the toxic effect of increased protein traffic across the glomeruli 
leading to sclerosis and vicious cycle. The rate of nephron 
destruction differs from one case to the other, ranging from few 
months to several years (Su etal., 2013).
 
If the diagnosis’s 
established and the appropriate treatment instituted accelerated 
deterioration of renal function could be reversed (Chan  et al., 
2002).Patient’s with treated with hem dialysis (HD) are at 
substantially increased risk of life-threatening infections. A 
majority of bloodstream infections are related to vascular 
access, of which 70 % are associated with the use of a central 
venous catheter (Patel et al., 2018). Infections result in significant 
morbidity and are second only to cardiovascular diseases as 






(ESRD) who is treated with dialysis. In addition to bacterial 
infections patients on HD are also susceptible to viral infections, 
including hepatitis B (HBV), hepatitis C (HCV), HIV, and 
influenza. Outbreaks of HCV infections in HD facilities, which 
continue to occur with disturbing frequency, have often been 
due to poor infection control practices (Nguyen et al., 2016). In 
September of 2016, the Centers for Disease Control and 
Prevention launched the Making Dialysis Safer for Patients 
Coalition to foster collaboration among dialysis organizations, 
physicians, public health officials, and patients. One of the top 
priorities for this coalition is prevention of bloodstream and 
other infections in patients on HD by increasing awareness 
among dialysis personnel and patients about ways to reduce 


























1.2 Problem of the study 
HCV and CMV are major cause of morbidity and 
mortality of renal failure among patients. Patients treated with 
hemodialysis are at substantially increased risk of life-
threatening infections. In addition to bacterial infections patients 
on HD are also susceptible to viral infections including hepatitis 
B , HCV, HIV, CMV, and   influenza. So the early diagnosis 
would help to reduce the infectious causes and also help in 
sorting the machine of HCV and CMV patients rather than other 
patients to study the prevalence of hepatitis C and 




















1.3The Objectives of the study 
1. To determine the contamination of dialysis machines by HCV 
and CMV. 
2. To study the effect age on HCV and CMV  IgM 
seropositivity.                 
3. To determine the prevalence of viral infection in kidney 
failure patients.  
4. To use serological test (Elisa IgM) to evaluation the 

























         An estimated 143 million people (2%) worldwide are 
infected with hepatitis C as reported in 2015. In 2013 about 11 
million new cases occurred1. It occurs commonly in Africa and 
Central and East Asia (WHO , 2016).
 
About 167,000 deaths due to liver cancer and 326,000 deaths 
due to cirrhosis occurred in 2015 due to hepatitis C. In Yemen 
HCV antibodies among general community showed a steady 
decline to less than 0.5% however among HCV risk groups such 
as dental workers and public health center workers, it was 5.5% 
and 11.5% respectively. Limited information is available among 
patients for dialysis in Yemen. HCV infection is more common 
among patients for dialysis than in healthy populations 
worldwide (Hanash et al.,2019). Renal failure in Sudan 
In Sudan there were 2858 patients on hemodialysis (HD) 122 
patients on continuous ambulatory peritoneal dialysis (CAPD), 
and 1168 kidney transplant recipients. The overall prevalence of 
treated ESRD was 106 patients per million populations. All 
forms of RRT were funded by the government. The mean age of 
HD, CAPD and kidney transplant patients was 46±17, 42±22 
and 39±13 years respectively. Males constituted 66%, 67.7% 
and 79.5% and children constituted 3.9%, 25.3% and 6.6% of 
HD, CAPD and kidney transplant patients respectively. 
The commonest reported cause of kidney failure was 
hypertension (26.1%), followed by diabetes mellitus (10.4%), 
obstructive uropathy (7.6%), glomerulonephritis (GN) (5.5%), 
polycystic kidney disease (2.6%), and pyelonephritis (1.1%). 






HD, 83.6% had a functioning arterio-venous (AV)  fistula, 6.4% 
were positive for hepatitis B virus  infection, 6.5% were positive 
for hepatitis C virus (HCV) infection, and 0.7% were positive 
for both HBV and HCV, target blood pressure, hemoglobin and 
phosphorus levels were achieved by 26.5%, 23.1% and 28.5% 
of HD patients compared to 41.8%, 20.6% and 63.5% of CAPD 
patients respectively .Kidney transplant recipients had their 
transplant operation performed in Sudan (33.1%), Egypt 
(20.7%), KSA (18.2%), Jordan (14.8%), Pakistan (8.4%) and 
cause of kidney failure other countries (Elamin et al.,2010). 
2.2. Hepatitis C Virus (HCV) and Cytomegalo Virus (CMV) 
Hepatitis B (HBV) and C (HCV) infections are considered as 
major public health problems worldwide. Prevalence of HBV 
and HCV infections in patients on maintenance hemodialysis is 
consistently higher than that in the general population because 
hemodialysis patients are at an increased risk of exposure to 
blood-borne viruses are including hepatitis B virus and hepatitis 
C virus ( Fabrizi et al., 2002).Several outbreaks and sporadic cases 
of nosocomial HCV or HBV transmission in HD units (HDUs) 
have been linked to the poor disinfection of dialysis equipment 
and poor compliance with standard infection control methods ( 
Rinonce et al.,2013). 
Prevalence of HBV and HCV among HD patients varies highly 
among countries and also among HDUs within a single country 
there is a high prevalence of HBV and HCV infections among 
HD patients in government hospitals in Indonesia. It is 
suspected that long-term HD and frequency of blood 
transfusions are possible causes of the high prevalence of HCV 
infection among HD patients which has remained high for a 
long period of time in Indonesia in spite of national dialysis 






by the Ministry of Health and Association of Indonesian 
Nephrologists (Utsumi et al., 2016). 
2.2.1. HCV Structure 
Hepatitis C virus non-structural protein contains serine protease 
and an RNA helicase, protease cleaves the genome encoded 
poly protein and inactivates cellular proteins required for innate 
immunity .Protease has emerged as an important target for the 
development of antiviral therapeutics, but drug resistance has 
turned out to be an obstacle in the clinic. Helicase is required for 
both genome replication and virus assembly. Mechanistic and 
structure studies of helices have hurled this enzyme in to a 
prominent position in the field of helices Enzymologists. Never 
the less, studies of helices anti-viral target remain in their 
infancy (   Raney et al .,2010). 
2.2.2 HCV genomes 
HCV genomes are single-stranded RNA, messenger positive 
sense RNA molecules the naked RNA initiates autonomous 
replication when transfected into cells and establishes chronic 
HCV infection in chimpanzees .The HCV genomic RNA carries 
genetic information at two levels  a single large open reading 
frame encodes viral proteins  and  complex RNA structural 
elements regulate the viral replication cycle Viral replication 
begins when conserved RNA elements in the 5′ UTR bind  the 
40S ribosome subunit and recruit essential translation factors. 
Translation produces a viral   poly protein that is cleaved by 
cellular and viral proteases to generate 10 viral proteins (Chu et 
al., 2013 ). The HCV genome is replicated through a negative-
strand RNA intermediate by a viral RNA-dependent RNA 
polymerase in a process controlled by conserved RNA elements 






compact and highly structure (Davis et al .,2008 ). These features   
likely facilitate persistent HCV infections in humans by 
protecting the genome from degradation by innate antiviral 
defenses ( Li and lemon , 2013).
 
Two elements of this defense are 
RNase L, which cleaves in single-stranded regions, and diverse 
double-stranded RNA-induced antiviral immune response (Floyd 
et al., 1981).
 
Selection of RNase L-resistant structures has likely 
led to the stable and compact HCV genome structure in contrast; 
concurrent selection imposed by the requirement to evade 
double-stranded RNA-triggered innate immune sensors likely 
constrains the lengths of internal helices (Peisley
  
and Hur 
,2013).Defining structural conformations of HCV RNA 
genomes is thus a critical step in understanding why human  
innate immune systems frequently fail to recognize and clear the 
virus, the structure  of  80%  of the hepatitis C virus  genome is 
unexplored. Most existing structural data have been obtained 
using short RNA transcripts that may not fully recapitulate 
structures in the intact genome. Here we used selective 2′-
hydroxyl acetylation analyzed by primer extension, read out by 
mutational profiling using massively parallel sequencing to 
model the structures of infectious HCV RNA genomes from 
genotypes 1a, 1b, and 2a. We developed a concise structure-first 
approach based on shape reactivity information to identify 
structural features conserved across HCV genotypes. We 
discovered conserved structural elements that influence viral 
replication and identified genotype-specific structures that likely 
facilitate evasion of cell (Davis et al., 2008). 
2.2.3 Virus replication  
The HCV replication cycle begins with entry into cells such as 
hepatocytes and leucocytes, possibly through interaction with 






synthesis seems to be partly regulated by positive and negative 
translational control elements in the 5' untran slated region of 
the mRNA. Cellular and viral proteins may switch these RNA 
control elements on a Since HCV is a positive sense RNA virus  
encapsulated viral RNA has the correct anatomy to serve in 
three ways: as a messenger RNA which is translated into viral 
proteins as a replication intermediate that is copied into a 
negative strand  and as a genomic RNA packaged into a virion 
RNA signals may be used by HCV to apportion the positive 
strand population  balancing the need for replication 
intermediates with the need for RNAs to be packaged into 
virions  and therefore helping to regulate the rate of replication. 
Anti-viral activities of the systemic immune system and anti-
viral factors produced within the virus-infected cell also strongly 
influence the rate of viral multiplication. The HCV replication 
complex has the potential to form double-stranded RNA a 
potent activator of intracellular anti-viral defiance pathways and 
interferon (IFN). Branch (1996) thus argues that through a 
combination of regulatory pathways built into the virus, 
intracellular anti-viral responses and the actions of the immune 
system HCV is suppressed following acute infection. Chronic 
HCV infection results from the battle between anti-viral 
responses and HCV replication and mutation. Because of the 
immune response during chronic infection the levels of HCV 
RNAs and proteins in the liver are very low almost undetectable   
although the liver is constantly bathed in blood containing HCV. 
However   HCV generally persists despite the immune response 
presumably despite a low rate of replication and perhaps 
reflecting the ability to infect and perhaps disarm the immune 







2.2.4. Transmission  
The infection can be transmitted through different routes. HBV, 
HCV are readily detected in serum. It is seen at very low levels 
in semen, vaginal mucus, saliva, and tears .The virus is not 
detected in urine, stool, or sweat .It is well documented that 
hemodialysis patients Have higher rates of HBV, HCV infection 
which proved by many studies done worldwide (Al-Faleh et 
al.,1999). Studies conclude that the transmission of is generally 
nosocomial with possible risk factors such as in proper 
disinfecting of devices between patients, sharing of single- use 
vials for infusion, poor sterile technique poor cleaning of 
dialysis machines  and poor distance between chairs(AAlkhan , 
2016). 
2.2.5 Diseases 
Hepatitis C virus (HCV) infection is a leading cause of chronic 
liver disease and hepato cellular carcinoma . A virus disease that 
affects the   liver. Clinical signs and symptoms include nausea, 
vomiting, abdominal discomfort and jaundice the average 
incubation period for the illness is 60-90 days and is transmitted 
via per cutaneous and mucosal exposure of infected body fluids 
(Raney et al., 2010). 
2.2.6   Immunity 
There is evidence from in vivo studies that at least some 
neutralizing antibody responses occur and that they are highly 
strain specific allowing other strains to emerge and perpetuate 
infection in the face of measurable neutralization. Thus host 
responses are generally unable to contain the emergence of 
neutralization-resistant variants there is also evidence from 






patients that there is no protective response against either 
heterogonous or homologous recalling (Farci et al .,1994). 
2.2.7 Treatment 
HCV the Current treatment is a combination pegylated 
interferon alpha and the antiviral drug ribavirin for a period of 
24 or 48 weeks (AAlkhan , 2016). 
2.2.8   HCV worldwide 
In sauna city study was screened 159 patients on long-term 
dialysis by HVC antibodies test, PCR HCV-RNA and HCV core 
antigen test by commercial tests. The prevalence of HCV was 
10.7% among patients undergoing dialysis .In this study was to 
determined prevalence of HCV genotyping and if HCV core 
antigen test could be a better alternative to NAT techniques for 
the most important results is that patients on maintenance HD in 
Yemen have a high prevalence of HCV infection comparing 
with general population and genotypes predominant. The 
performance of serological detection of HCV core antigen was 
better than that of HCV antibodies test and may be an 
alternative to nucleic acid amplification technology (NAT) for 
routine monitoring of patients on chronic dialysis ( Hanash et al., 
2019). 
In Italy preventing HCV infection among hemodialysis patients 
A cross-sectional survey has been conducted among nurses in 
Calabria region (Italy) in order to acquire information about the 
level of knowledge, the attitudes and the frequencies of 
evidence-based practices that prevent hospital transmission of 
HCV. Methods: All 37 hemodialysis units (HDU) of Calabria 
were included in the study and all nurses were invited to 
participate in the study and to fill in a self-administered 






participated in the study. Correct answers about HCV pattern of 
transmission ranged from 73.7% to 99.3% and were 
significantly higher in respondents who knew that isolation of 
HCV-infected patients is not recommended and among those 
who knew that previous bloodstream infections should be 
included in medical record and among nurses with fewer years 
of practice. Most correctly thought that evidence-based in 
fiction control measures provide adequate protection against 
transmission of blood borne pathogens among healthcare 
workers. Positive attitude was significantly higher among more 
knowledgeable nurses (Bianco et al., 2013). 
He estimated the prevalence of HBV and HCV infections 
among hemodialysis patients, to determine the risk factors of 
hepatitis B and C infection in hemodialysis patients. To assess 
Level of awareness of the patients and health care workers about 
the HBV and HCV infections The prevalence of HBV and HCV 
infections varies greatly from country to country, with 14% of 
hemodialysis patients in Saudi Arabia being hepatitis B positive 
and 7% of them being hepatitis C positive. In other Arab He 
founded Among all risk factors were studied, only the long 
duration of hemodialysis was significantly associated with HBV 
and HCV positivity suggesting that HBV and HCV were 
nosocomial transmission and the no adherence to the known 
universal infection control precautions could be contributing to 
the high prevalence. Education of staff members and adhere 
strictly to universal infection control precautions remains a 
cornerstone for prevention of hepatitis transmission among 
patients undergoing maintenance hemodialysis (AAlkhan   ,2016). 
In Libya survey was thus designed to determine the extent of the 
problem at the national level. A multistage sampling design 
covering all administrative areas of Libya was applied covering 






sample and completed a questionnaire on demographic and risk 
behavior data. The prevalence of HBV surface antigen (HBs 
Ag) and anti-HCV were 2.2% and 1.3% respectively. The 
prevalence of anti-HCV increased with age, rising gradually 
after age 30 years, in contrast to a stable prevalence of HBs Ag 
in all age groups 10+ years. Age-adjusted risk factors for HCV 
infection were previous hospitalization, surgical operations, 
previous blood transfusions and intravenous drug use for HBV 
infection only family exposure or contact with HBV case were 
identified ( Elzouki  et al .,2013)]. 
The prevalence of viral infections among Egyptian 
children with end stage renal disease whether on conservative 
management or on hemodialysis and to identify the possible 
associations between viral infections and some clinical 
parameters, in this study included 50 patients with end stage 
renal disease, all patients were subjected to full history, 
thorough clinical examination and laboratory investigations in 
the form of complete blood count, renal function tests, and 
serum electrolytes. Abdominal ultrasound and echocardiography 
were also done. In addition virological screen was assessed 
(conventional PCR for HCV, HGV and CMV and ELISA for 
HBV, HCV and HIV).HCV antibodies were detected by ELISA 
test in 15% of patient on conservative management and in 
43.3% of patients on hemodialysis therapy P =0.035. No 
antibodies for HBV and HIV were detected in our patients. 
Significant association was found between viral infections and 
patient's age (P= 0.043). Also significant association was found 
between viral infections and duration of hemodialysis 
(P=0.015). But no significant associations were found between 
viral infections and both frequency of dialysis settings 






To assess the incidence rate of hepatitis C virus infection in 
hemodialysis units and explore its potential risk factors. Five 
electronic databases were used to search articles from 1990 to 
2012 including Pub Med Embassy, China National Knowledge 
Infrastructure, Chinese Biomedical Literature Database, and 
Wan fang. A random-effects analysis was used to estimate the 
overall incidence rate of hepatitis C virus infection. A subgroup 
analysis and meta-regression analysis were conducted to explore 
factors associated with heterogeneity between studies. Twenty-
two eligible articles were found, including 23 incidence rate 
estimates. The overall incidence rate of hepatitis C virus 
infection was 1.47 per 100 patient-years (95%) ( Yanging et al 
.,2013).  
In Sudan the epidemiology of hepatitis B virus (HBV) and 
hepatitis C virus (HCV) is important for health planners and 
service providers. A cross‐sectional study was conducted by 
Hamada To investigate the sera prevalence and associated risk 
factors for markers of HBV (HBs Ag) and anti‐HCV among 
hemodialysis patients at the Ahmed Gasim hemodialysis unit 
Sudan. Of the 353 patients enrolled in the study, HBsAg and 
anti‐HCV were detected in 16 (4.5%) and 30 (8.5%) patients 
respectively none of the patients were co‐infected with HBV 
and HCV multivariate analysis showed that duration of dialysis 
was significantly associated with anti‐HCV sero positivity ( 1.1, 
95% , P=0.02(Gasim etal .,2012). 
2.3 Cytomegalovirus (CMV) 
CMV is a member of the genus herpes virus and belongs 
to the family Herpes viridae CMV is common causes of human 
disease and CMV infections   usually a symptomatic in 
otherwise healthy children and adults, CMV is more wide 






socioeconomic conditions, such as lower rates of CMV infection 
were reported in Europe parts of North America and Australia 
while higher rates were reported in Africa and Asia( Crough and 
Khanna ,2009). 
 2.3.1. Structure of CMV 
Compared to other human herpes virus  HCMV is the largest  
with a genome of 235 kb encoding 165 gene  the virion consists 
of double  stranded linear DNA core in an icosahedral 
nucleocapsid, enveloped by a proteinacous matrix ( the 
tegument). These components are enclosed in a lipid bilayer 
envelope that contains a number of  viral glycoprotein's  these 
include glycoprotein B (gB), gH, gL, gM, gN and gO, mature 
visions range in diameter from 200 to 300 nanometer ,The 
tegument compartment contain the majority of the virion 
proteins, with the most abundant tegument protein being the 
lower matrix phosphor protein 65 (pp 65), also termed Unique 
Long 83(TUL83) , the function of the tegument proteins can be 
separated in to two classes : (i) protein that play a structural role 
and are important for the assembly of the visions and the 
disassembly of the particle during entry and  (ii) protein which 
modulate the host cell response to infection   ( Crough and Khanna 
,2009). 
2.3.2 Classification 
Cytomegalovirus formally designated as human herpes virus 5 
(HHV-5) by the International Committee on Taxonomy of 
Viruses, is a member of the family Herpes viridae    and it is 
classified in the subfamily Beta herpes virinae. Human CMV 
(HCMV) is the type species of the genus cytomegalovirus and 
its name is derived from the enlargement of cells (cyto=cell, 






virus is based on its tendency to infect mononuclear cells and 
lymphocytes - and on its molecular phylogenetic relationship to 
other herpes viruses .Its classification as a beta herpes  virus is 
based on its long replication cycle, cy to pathology, and 
restricted host range which are all characteristic of the beta 
herpes viruses (Todd and Wills ,2006). 
2.3.3 Properties of CMV 
Cytomegalovirus has largest genetic content of the human 
herpes virus. It’s DNA genome (240 kbp) is significantly larger 
than that of herpes simplex virus. Only a few of many proteins 
encoded by the virus (over 200) have been characterized. One a 
cell surface glycoprotein, act as Fc receptors that can 
nonspecifically bind the Fc portion of immunoglobulin's .This 
may help infected cells evade immune elimination by providing 
a protective coating of irrelevant host immunoglobulin's The 
major immediate early promoter - enhancer of CMV is one of 
the strongest known enhancers due to the concentration of 
binding sites for cellular transcription factors. It is used 
experimentally to support high - level expression of foreign 
genes. Many genetically different strains of CMV are circulating 
in the human population. The strains are sufficiently related 
antigenic ally, however so  that strain differences are probably 
not important determinants in human disease Cytomegalo virus 
is very species - specific and cell type-specific .All attempts to 
infect animals with HCMV have failed. A number of animal 
CMV exists all of them species - specific. HCMV  replicates in 
vitro only in human fibroblasts although the virus is often 
isolated from epithelial cells of the host. CMV replicate very 
slowly in cultured cells with growth proceeding more slowly 
than that of HSV or varicella zoster virus. Very little virus 






CMV may take several weeks for an entire monolayer of 
cultured cells to become CMV produces a characteristic 
cytopathic effect, pronuclear cytoplasmic inclusion form in 
addition to the intra nuclear inclusion typical of herpes viruses  
multinucleated cells are seen  many affected cell become greatly 
enlarged inclusion-bearing cytomegalic cells can be found in 
samples from infected  individuals ( Brooks et al .,2010). 
2.3.4   Replication of CMV. 
Cytomegalovirus attaches to cell surface at the site of the 
receptor for fibroblast growth factor. After entry into the cell the 
virion is uncoated and the genome DNA enters the nucleus. 
Within the nucleus, the incoming genome DNA changes its 
configuration from linear  to circular. Early virus messenger 
RNA (mRNA) is transcribed by host cell RNA polymerase and 
then translated into early nonstructural proteins in the 
cytoplasm. The viral DNA polymerase replicates the genome 
DNA and late protein synthesis begins. Then the virion 
assembly occur in the nucleus. The virion obtain its envelope by 
budding through the nuclear membrane and exits the cell via 
tubules or vacuoles that communicate with the exterior 
(Luraine  etal ., 2013). 
2.3.5Transmission                                              
Human cytomegalo virus approximately 40%-100% of all adults 
world wide are asymptomatic carriers of this virus Major 
transmission routes of HCMV include direct person-to-person 
contact, tissue and organ transplantation and transfusion of 
blood products, HCMV is also the most common viral cause of 
morbidity, graft loss, and mortality in immune compromised 






recipients (such as hemodialysis patients) respectively   ( Sia and 
patel ,2000). 
2.3.6. HCMV diseases  
CMV infection during pregnancy is great clinical importance 
since it can affect the mother's health or even cause mortality 
and infection-related congenital abnormality in fetus and 
newborns. The virus can also cause pneumonia is, enter colitis, 
nephritis, diabetes, hepatitis and cardiac complications Similar 
to other members of the Herpes viridae family, CMV can persist 
in the host in a latent state following primary infection, and 
increase the risk of other opportunistic infections such as 
Epstein-Barr virus and human herpes virus 6 ( Sia and Patel ,2000). 
2.3.7 Immunity  
HCMV is a potent immunogen that trigger strong immune 
response from all arms of the immune system, while the 
contribution of antibodies for protection against and control of 
HCMV has been debated, evidence does support a role for 
humeral immunity in the effective immune response against 
HCMV, predominantly in restricting viral dissemination and in 
limiting the severity of the disease ( Boppana and Britt ,1995). The 
cell mediated immune response is the predominant mechanism 
by which HCMV replication is controlled   , as with the 
exception of congenital infection, severe HCMV disease occurs 
almost exclusively in patient with profound cellular immune 
deficiency .The innate immune system plays an important role 
in defiance against HCMV and also in priming the adaptive 
immune response. It is becoming   increasingly apparent that 
HCMV is subject to innate sensing by toll – like receptor 
(TLRs). The stimulation of TLRs by pathogens such as HCMV   






secretion of inflammatory cytokines that recruit cells of the 
innate immune system, and the up regulation of stimulatory 
molecules such as CD80 and CD86, which are important for 
activation of adaptive immunity (  Boehme and Compton ,2004). 
The establishment of long - lasting immunity in response to a 
primary   HCMV infection which serves to control subsequent 
HCMV reactivation in   the host   is important for preventing 
uncontrolled replication and serious  ( Crough  and khanna ,2009). 
2.3.8 CMV Worldwide 
In Sana City (Yemen)  study to determining the prevalence 
of cytomegalovirus (CMV) antibodies in renal failure patients 
who undergoing hemodialysis this study was conducted from 
the period 1/3/2014 to 30/10/2014 in Ibn-Sina Center for 
Dialysis in Diyala province. Sera of 91 hemodialysis patients 
were investigated for CMV-specific immunoglobulin G (IgG) 
using enzyme-linked immune sorbent assay (ELISA). Fifty-two 
(57.14%) patients were males and thirty-nine (42.85%) were 
females. 87 patients (95.60%) were anti-CMV IgG positive and 
4 patients (4.39%) were anti-CMV IgG negative. There was no 
difference in CMV prevalence between males (94.2%) and 
females (97.4%). Seventy two patients (79%) reported history of 
blood transfusion. There was no relationship between the 
antibody titer and dialysis duration (   Salman et al .,2014). 
In Gorgan, study Blood samples were taken from 149 
hemodialysis patients at Hemodialysis Unit of Panje-Azar 
Medical Centre in Gorgan. Plasma was separated from whole 
blood, aliquot and stored at -70°C until processing, demographic 
information and medical history of patients were recorded; 
Plasma level of CMV-IgM antibody was measured by enzyme 
linked immune sorbent assay kits (IgM-Dia.ProInc Third 






instructions. DNA was extracted from 200 µL of EDTA anti 
coagulated plasma using a commercially available kit (High 
Pure Extraction Kit; Roche Diagnostics GmbH, Mannheim, 
German), the most important results is that total prevalence of 
CMV infection was 6.7% (10/149) among the patients receiving 
hemodialysis. CMV-DNA and anti-CMV IgM antibody were 
detected in 2.68% and 4.69%, of the samples, respectively. One 
case was found positive for both CMV-DNA and anti CMV IgM 
antibody (Kelishadi et al ., 2017). 
CMV infection did not have any correlation with gender, age, 
ethnicity duration of hemodialysis and history of blood 
transfusion. 
In  Iran study to determining the prevalence of cytomegalovirus 
(CMV) antibodies in end-stage renal disease (ESRD) patients 
who undergo hemodialysis. Across-sectional study of 
hemodialysis patients in Urmia Iran Sera of 84 Hemodialysis 
patients were investigated for CMV-specific immunoglobulin G 
(IgG). Forty-four (52%) patients were males. 65 patients 
(77.4%) were anti-CMV IgG positive and 6 (7.1%) were anti-
CMV IgM positive. There was no relationship between the 
antibody titer and dialysis duration or frequency of HD in a 
week (Sepehrvand et al  ., 2010). 
In Tanta City, the prevalence of CMV infection in patients 
undergoing hemodialysis and to compare the results of different 
serological tests for CMV    infection . Data were collected from 
100 patients with renal failure and undergoing hemodialysis in 
the hemodialysis center of health insurance hospital in Tanta 
City, Gharbia Governorate, Egypt during the period from 
January 2007 to January 2008. The data collected from the study 
patients included socio demographic characteristics, history of 
blood transfusion and duration of hemodialysis. CMV/IgG, 






studied patients. Cross-tabulation and Fisher exacts and 
McNamara’s tests as well as concordance agreement tests were 
used. The mean age of the study patients was 42.0 ± 8.1 and 
most of them (60%) were males with the mean duration of 
dialysis was 1.8 ± 1.1 years. The seroprevalance of CMV 
antibodies among these acute patients was 98% using 
CMV/IgG, 11% using CMV/IgM and 30% by using 
CMV/Ampilcor (PCR). Comparing these findings showed 
highly statistically significant difference (P= 0.001). Sensitivity 
and specificity of CMV/IgG and IgM were varied compared to 
CMV/ Ampilcor test. The IgM was less sensitive (30%) but 
highly specific (97%), so PCR is the gold standard test with 
concordance estimated to be 28%. For this test, sensitivity and 
agreement is increased with decreasing years of dialysis to 
become 40% and 43% respectively. On the other hand   however  
CMV/IgG appeared to be highly sensitive (93%) and not 
specific at all (0%)  and the agreement with PCR is very low 
(3%). In summary the choice of diagnostic IgM and IgG tests 
depends upon the duration of hemodialysis that might primarily 
determine the duration of infection, although the use of PCR 
testing appeared to be more convenient ( El-Sadek and Morsy  
,2008). 
In   study to   analyze the prevalence of HSV-1, HSV-2, 
VZV, CMV and EBV in patients undergoing hemodialysis. 
During a three-year period (2013-2015)  152 consecutive serum 
samples from hemodialysis patients and 150 healthy subjects 
(control group) were tested for the presence of IgM/IgG 
antibodies to herpes group viruses. Serologic tests were 
performed using a commercial enzyme-linked immune sorbent 
assay (ELISA) or enzyme-linked immune fluorescent assay 
(ELFA). Hemodialysis patients showed significantly higher 
CMV Ig Gsero positivity compared to controls (88.2% vs. 






VZV were higher in hemodialysis patients; however, these 
differences did not reach statistical significance (85.5% vs. 
80.0%, p=0.054 and 99.3% vs. 96.0% p=0.051  respectively ). 
The prevalence of HSV-2 and EBV was similar in both groups 
(12.5% vs. 12.7%, p=0.137 and 98.0% vs. 95.3%   p=0.113  
respectively ).There was no difference in IgG sero positivity 
according to gender and place of residence. Logistic regression 
showed that older age was a significant predictor for CMV and 
EBV IgG sero positivity (increase in age by one year: CMV 
OR=1.055; 95%CI=1.030-1.080 and EBV OR=1.075 (  Vilibic- 
Cavlek et al  .,2017). 
2.3.9 CMV in Sudan:  
In Sudan the Blood samples were collected randomly from 
52 renal transplant patients and 41 haemoidalysis patients the 
sera were tested with an enzyme linked immune sorbent assay 
(ELISA) for HCMV IgG antibodies and additional ELISA test 
for HCMV IgM antibodies .the most important Results is that 
Renal transplant screening revealed that 98% of patients have 
IgG for HCMV antibodies and only 6% have IgM antibodies .In 
hemodialysis patients 95% showed the presence of IgG 
antibodies to HCMV and none of patient revealed the presence 
of IgM antibodies ( Awadalkareem et al .,2013). Across 
sectional study was conducted at Gezira Hospital for Renal 
Diseases and Surgery (GHRDS) in 93 hemodialysis patients. 
Indirect Enzyme-linked immune sorbent assay (ELISA) was 
used to investigate anti-CMV IgM and IgG. Structured 
questionnaire was used to gather socio demographic data. In 
hemodialysis patients, the positivity for anti-CMV IgM and anti-
CMV IgG were found in 45.2% (42/93) and 95.7% (89/93) 
respectively. The number of hemodialysis patients subjected to 
blood transfusion and previous surgery were 79 (84.9%) and 42 






anti-CMV IgG were 45.6% and 97.5%, 47.6% and92.9% among 
hemodialysis patients received blood transfusions and subjected 
to previous surgery respectively (Abd Alla  et al.,2015). 
 To perform serological detection of cytomegalovirus antibodies 
among Sudanese renal transplant recipients. One hundred and 
four selected renal transplant recipients were enrolled in this 
cross-sectional study. Blood specimens were collected and 
investigated for the presence of CMV IgG and IgM antibodies 
using the enzyme-linked immune sorbent assay (ELISA). From 
a total number of 104 renal transplant recipients, 27 (26%) out 
of them were positive for CMV IgM antibody, while 103 (99%) 
were positive for CMV IgG antibody. The frequency rate of 
sero-positive CMV antibodies was high among the Sudanese 
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CHAPTER THREE  
MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Area of study 
In Khartoum state and El-gaziera state (giad region) . 
3.1.2Duration of study 
The study was carried out during the period from April to 
October 2019. 
3.1.3 Sample collection 
A total of 91 specimens were collected from hemodialysis 
machines of Al akademy , police, Bashiar and giad hospitals( 
aljazeera state)  and investigated for HCV and CMV – specific 
immunoglobulin IgM. The age of all hemodialysis patients 
tested ranged from 15 to 90 years, blood samples were collected 
under aseptic conditions allowed to clot centrifuged at 1600 rpm 
for  5 minutes , and blood were collected in sterile containers 
and stored at -34 ° C until tested. 
3.1.4 Data collection 
Personal and clinical data were collected by direct interviewing 
questionnaire from each subject. 
3.1.5 Equipments 








3.2 HCV Methods 
Commercial ELISA Kits (Fortress Diagnostics Limited 
Unit2C Antrim Technology park Atrim BT41 1QS (United 
Kingdom).) was used to detect the specific HCV IgM 
antibodies. 
3.2.1 Principle 
The anti HCV- ELISA is based on the classical ELISA 
technique, the micro titer strip wells as solid phase were coated 
with cell culture derived HCV antigens (HCVAb). In the first 
incubation step cores pending specific antibodies (HCV-IgM-
Ag) present in patient specimens or control bind to the antigens 
at the solid phase  the sample dilution buffer contaminant human 
IgM to prevent Rheumatoid Factor (RF) interference and 
competition for specific IgM present in the specimen .At the end 
of the incubation  unbound components are washed out for the 
second incubation step anti IgM conjugate (anti-human IgM 
antibodies peroxides conjugate) is added which binds 
specifically to IgM antibodies resulting in the formation of 
typical immune complexes after a second washing step to 
remove excess conjugate HRP/Substrate is added (step 8).A 
blue color develops changing to yellow after stopping the 
reaction  the intensity of the color is directly proportional to the 
HCV –IgM-Ab concentration in the specimen. 
The absorbance of control and specimen is determined by using 
ELISA Micro plate reader. Result for patient samples are 
obtained by comparison with cut-off value. 
3.2.2 Procedure 
Reagent preparation all reagents and samples were brought to 
roomtemperature for30-60minutesbeforebeginningtheprocedure.                                                                                                       






washing solution diluted with fresh deionizer water, other 
reagents were ready for use. 
All the steps for the procedure used following for the detection 
of the HCV IgM: 
-  Adding diligent: one hundred ml of sample diluent was added 
into each well except the blank. 
- Adding sample: tine ml of sample, positive and negative 
control was added into the irrespective well mix by tapping the 
plate gently. 
-  Incubating sample :was  covered the plate and incubate for 
60min at37c at room. 
-  Washing :  after the end of incubation abscise and discard the 
plate cover for30minutes. 
- Washing :   after the end of the incubation was removed and 
discard the plate sealer aspirate each well 5times with each well 
5 times after washing cycle turn down the plate on blotting 
paper to remove any reminders.                                                                          
 -  Adding HRP-Conjugate : was  added 100ml of HRP- 
conjugate reagent into  each well except blank well                                     
-  Incubating HRP -conjugate: cover the plate and  incubated for 
30min at 37c. 
- Washing: was removed  and discard the plate sealer aspirate 
each well 5times with wash buffer after washing cycle turn the 
strips plate and tap about any remainders 
- Coloring: fifty ml of Chromogenic A and Chromogenic B was 
added into well including the blank and mix by tapping the plate 
gently incubated the plate at room temperature for 20 min. 
- Stopping reaction: fifty ml  of stop solution was  added  into all 
wells and mix by tapping the plate gently. 
- Measuring the absorbance:  was calibrated the plate (micro 
well) reader with 450nm (reading)  and with blank well reader 






3.2.3 Calculation of control values and cut-off 
Mean absorbance values of negative control (MNC) and mean 
absorbance value of positive control  (MPC) were calculated.  
The cut-off value was then calculated following this equation: 
Cut-off value = NC +0.12  
3.2.4 Interpretation of the results 
Sample with the absorbance >1.0  were considered as anti - 
HCV -IgM -Ab positive, while samples with absorbance < 1.0  
were as anti-HCV- IgM- Ab- negative. 
3.3 CMV Methods: 
Commercial ELISA Kits (Dia .Pro .Diagnostic BioprobesSrl Via 
G.Carducci n27 -Sesto San Giovanni Milano-Italy  ) was used to 
detect the specific HCV and CMV IgM antibodies . 
3.3.1 Principle 
The CMV IgM ELISA is based on the classical ELISA 
technique The micro titer strip wells as solid phase were coated 
with cell culture derived CMV antigens (CMV Ag). In the first 
incubation step corresponding specific antibodies (CMV-IgM-
Ab) present in patient specimens or controls bind to the antigens 
at the solid phase , the sample dilution buffer contains anti 
human IgM to prevent Rheumatoid Factor (RF) interference and 
competition for specific IgM present in the specimen . 
At the end of the incubation, unbound components are washed 
out for the second incubation step anti IgM conjugate (anti-
human IgM antibodies peroxides conjugate) is added which 
binds specifically to IgM antibodies resulting in the formation of 
typical immune complexes after a second washing step to 
remove excess conjugate TMB /Substrate is added (step 3).A 






reaction  the intensity of the color is directly proportional to the 
HCV and CMV –IgM-Ab concentration in the specimen. The 
absorbance of control and specimen is determined by using 
ELISA Micro plate reader. Result for patient samples are 
obtained by comparison with cut-off value. 
3.3.2  Procedure 
Reagent   preparation All reagents and samples were brought to 
room temperature for 60minutes before beginning the 
procedure.       
  The serum samples were diluted with dilution buffer IgM and 
washing solution diluted with fresh deionizer water, other 
reagents were ready for use. 
All the steps for the procedure used following for the detection 
of the CMV IgM.: 
-  Adding diluent: one hundred ml of sample diluent was added 
into each well. 
-  Adding sample : one hundred ml of  sample  was  added  into 
each well 
- Adding control: one hundred ml  of positive control was added  
into respective well. 
- Adding control : one hundred ml  0f negative control was 
added into respective well. 
-  Incubating sample :was  covered the plate and incubate for 
60min at37c at room. 
- Washing :  after the end of incubation abscise and discard the 
plate cover wash each well 5 times after washing cycle turn 
down the plate on blotting paper to remove any reminders.-  
Adding antigen (AGCMV) complex: was  added 100ml of Ag 
CMV-conjugate reagent into  each well except blank well -  
Incubating Ag cmv -conjugate: cover the plate and  incubated 






-  Washing: was removed  and discard the plate sealer aspirate 
each well 5times with wash buffer after washing cycle turn the 
strips plate and tap about any remainders. 
-Coloring: one hundred ml of chromate/substrate 
(TMB/H2O2)was added into well including the blank incubated 
the plate at room temperature for 20 min. 
- Stopping reaction:  one hundred ml of Sulphuric Acid was  
added  into all wells. 
- Measuring the absorbance:  was calibrated the plate (micro 
well) reader with 450nm (reading) and with blank well reader 
620-630nm (blanking).     
3.3.3  Calculation of control values and cut-off  
Mean absorbance values of negative control (MNC) and mean 
absorbance value of positive control   (MPC) were calculated.          
The cut-off value was then calculated following this equation: 
Cut-off value = NC +0.250. 
The test run was validated according to the manufacturer's 
criteria for validity as below : 
-  Ab substrate blank < 0.150 
-  MNC < 0.250 
-  MPC > 0.400 
3.3.4  Interpretation of the results 
Sample with the absorbance >1.2  were considered as anti - 
CMV -IgM -Ab positive while samples with absorbance < 1.0  









 3.3.5 Data analysis 
The statistical package of social science (SPSS) was used for 
statistical analysis. Significance of difference was determined 
using Chi-square test. 
Statistical significance was set at P < 0.05. Figures were 
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CHAPTER FOUR  
RESULTS AND DISCUSSION 
4.1 Results  
ELISA test was done for HCV and HCMV  Samples obtained 
from dialysis machines from different hospitals in Khartoum 
state and hospital of Giad region (Aljazeera state ) and we found 
that for HCV all 91 samples hemodialysis patients were 
investigated  used enzyme-linked immune sorbent assay 
(ELISA)   were negative. also Sera of 91 haemodialysis patients 
were investigated for  CMV used enzyme-linked immune 
sorbent assay (ELISA) and we  found that eight samples ( 7.3%) 
were positive for anti I g M :  
 Giad hospital three   (2.7%) were positive, two males (1.82%) 
ages 49, 29 years one female was positive (0.9%), aged 37 years 
   Police hospital three (2.7%) positive, one female was positive 
(0.9%) aged 48 years and two males (ages were 54, 67 years) 
were positive (1.8%). 
   Bashiar one male was positive (0.8%) aged 56years   .   
   Academy one male was positive (0.8%) age 89 years . 











Table 4.1: frequency of subject by area 
On hospitals (Police   . academy .  Bashiar . Giad ) 
Hospitals Negative Positive 
 Mail Female Mail Female 
Police 77 76 0.0 % 0.0 %  
Acadimy 5 7 0.0 %  0.0 %  
Bashiar 75 77 0.0 %  0.0 %  





0.0 %  0.0 %  
 
 Table 4.2 : HCV frequency of subject by age  
 (Police.  Academy.  Bashair  . Giad  ) 
Hospitals Aga No 
Police 50  0 70ـــ 
Acadima 80  0 90ـــ 
Bashiar 50  0 60ـــ 




















Figure 4.1: frequency by place  CMV on Hospitals 


































Figure 4.2:  frequency by age C M V 
On hospitals (Police . Acadimy .  Bashiar . Giad ) 

























Patients treated with hemodialysis are at substantially 
increased risk of life-threatening infections. A majority of 
bloodstream infections are related to vascular access, of which 
70 % are associated with the use of a central venous catheter 
(Patel et al., 2017).In addition to bacterial infections   patients 
on HD are also susceptible to viral infections, including hepatitis 
B (HBV)  hepatitis C (HCV), HIV, and influenza. Outbreaks of 
HCV infections in HD facilities, which continue to occur with 
disturbing frequency, have often been due to poor infection 
control practices (Nguyen DB etal.,2 016). In this study 91 
blood specimens were collected from hemodialysis machines 
from different hospitals of Khartoum state and Giad hospital in 
Elgaazira state to investigate HCV and CMV – specific 
immunoglobulin IgM. Specimens were collected from both 
males and females with different ages n we found that , age 
group was 15 to 90 years (male :54 and females:37)  all results 
revealed negative for HCV ELISA test Similar study in Sudan 
by   Gasim etal., (2012). a cross sectional study was conducted 
To investigate the sero prevalence and associated risk factors for 
markers of anti HCV among hemodialysis  patients at the 
Ahmed Gasim hemodialysis unit . Of the 353 patients enrolled 
in the study, anti HCV were detected in 30 (8.5%) patients 
multivariate analysis showed that duration of dialysis was 
significantly associated with anti HCV sero positivity ( 1.1, 95%  
P=0.024).Also in Libya Elzouki etal . (2013) stated that, the 
prevalence of  anti-HCV were 1.3%. The prevalence of anti-
HCV increased with age, rising gradually after age 30 years. 
Age-adjusted risk factors for HCV infection were previous 
hospitalization, surgical operations, previous blood transfusions 
and intravenous drug. Alkhan et al. (2015) mentioned that, in 






among hemodialysis patients, and  risk factors of hepatitis C 
infection . To assess Level of awareness of the patients and 
health care workers about the HCV infections, the prevalence of 
HCV infections varies greatly from country to country, 
hemodialysis patients in Saudi Arabia being of 7% hepatitis C 
positive only the long duration of hemodialysis was significantly 
associated with HCV positivity suggesting that HCV was 
nosocomial transmission.Also this study was done for detection 
the CMV using ELISA test anti IgM for same blood samples 
(group, size and hospitals) and we found that  total of positive 
samples were 8 ( 7.3%)  males were 7 ( 6.4%) and females was 
one (0.9%)  the negative samples were 83 (75.5% ). 
 Similar results obtained by Kelishadi etal.,2017 in Gorgan(Iran) 
when blood samples were taken from 149 hemodialysis patients 
at Hemodialysis Unit of Panje-Azar Medical Centre . Plasma 
level of CMV-IgM antibody was measured by enzyme linked 
immune sorbent assay, the most important results is that total 
prevalence of CMV infection was 6.7% (10/149) among the 
patients receiving hemodialysis. Awadalkareem et al.,2013 
stated that   in Sudan  the Blood samples were collected 
randomly from 52 renal transplant patients and 41 
haemodialysis patients.The sera were tested with an enzyme 
linked immune sorbent assay (ELISA) for HCMV IgG 
antibodies and additional ELISA test for HCMV IgM 
antibodies.The most important Results is that Renal transplant 
screening revealed that 98% of patients have IgG for HCMV 
antibodies and only 6% have IgM antibodies.In hemodialysis 
patients 95% showed the presence of IgG antibodies to HCMV 
and none of patient revealed the presence of IgM antibodies. 
Abu Algasim  .,2016 showed that in  across sectional study 
conducted at Gezira Hospital (Sudan)  for Renal Diseases and 






hemodialysis patients. Indirect Enzyme-linked immunosorbent 
assay (ELISA) was used to investigate anti-CMV IgM and IgG. 
In hemodialysis patients, the positivity for anti-CMV IgM and 
anti-CMV IgG were found in 45.2% (42/93) and 95.7% (89/93) 
respectively. The number of hemodialysis patients subjected to 
blood transfusion and previous surgery were 79 (84.9%) and 42 
(45.2%) respectively. The percentage of anti-CMV IgM and   
anti-CMV IgG were 45.6% and 97.5%; 47.6% and92.9% among 
hemodialysis patients received blood transfusions and subjected 
to previous surgery respectively.Also high level of CMV was 
found by Hind Ahmed and Al Fadhil Omer, 2018 to when 
cytomegalovirus antibodies among Sudanese renal transplant 
recipients was investigated in one hundred and four selected 
renal transplant recipients were enrolled in this cross-sectional 
study. Blood specimens were collected and investigated for the 
presence of CMV IgG and IgM antibodies using the enzyme-
linked immune sorbent assay (ELISA).From a total number of 
104 renal transplant recipients, 27 (26%) out of them were 
positive for CMV IgM antibody, while 103 (99%) were positive 
for CMV IgG antibody. The frequency rate of sero-positive 


























CONCLUSION AND RECOMMENDATION 
5.1 Conclusion 
 There was a low sero-prevalence of CMV antibodies among 
haemodialysis machines in this study in Khartoum state in 
Giad Hospital (the academy, Bashar and the police). CMV 
infection may due to contaminating machines and non-
Consider   allocating haemodialysis   machine for infected 

























_ Increase the number of samples. 
_The   use of modern methods of  diagnosis . 
_ Attention to sterilizing hemodialysis . 
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